FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
https://doi.org/10.15789/1563-0625-2013-6-577-584
Abstract
Abstract. In this study, we have identified functional features of immune system cells in patients with acute lymphoblastic leukemia (ALL), depending on clinical stage of the disease. At all stages of the disease, the patients developed T-cell immunodeficiency. A decrease in T lymphocyte scores and diminished CD4/CD8 ratio was associated with development of primary ALL attack. An increase in NK-cells was typical to ALL relapse. In general, ALL cell populations were characterized by a significant reduction of intracellular metabolic processes in lymphocytes. Chemiluminescent activity of neutrophil granulocytes changed in ALL patients with disease progression, being intensified at the stage of primary attack, followed be decreased activity during complete clinical remission and relapse, probably, due to depletion of internal reserves. The study confirmed that significant changes in ALL are associated with functional and metabolic state of lymphocytes and neutrophils upon progression of the disease, which is probably responsible both for development of complications, but it also may influence relapse risks and determine worse prognosis in general.
About the Authors
O. V. SmirnovaRussian Federation
PhD, MD (Medicine), Chief, Laboratory of Clinical Pathophysiology and Allergology
660022, P. Zhelesniak str., 3g. Phone/fax: 7 (913) 567-97-19
V. T. Manchuk
Russian Federation
PhD, MD (Medicine), Professor, Corresponding Member, Director
References
1. Василевский М.Г., Камарли З.П. Статистика и проблемы гемобластозов // Вестник Кыргызско-Российского славянского университета. – 2007. – Т. 7, № 9. – С. 84-89. Vasilevskiy M.G., Kamarli Z.P. Statistika i problemy gemoblastozov [Statistics and problems Leukemia]. Vestnik Kyrgyzsko-Rossiyskogo slavyanskogo universiteta – Bulletin of the Kyrgyz-Russian Slavic University, 2007, vol. 7, no. 9, pp. 84-89.
2. Воробьев А.И. Руководство по гематологии в 3-х томах. Т. 1. – М.: Ньюдиамед, 2002. – 280 с. Vorobyov A.I. Rukovodstvo po gematologii v 3-kh tomakh. T. 1. [Guide to Hematology in 3 volumes. Vol. 1.]. Moscow, Nyudiamed, 2002. 280 p.
3. Галстян Г.М., Кесельман С.А., Городецкий В.М. Алексанян М. Ж., Куликов С. М., Гемджян Э. Г., Паровичникова Е. Н., Савченко В. Г., Воробьев А. И. Сочетанное проведение химиотерапии гемобластозов и терапии острой дыхательной недостаточности в реанимационных условиях // Терапевтический архив. – 2009. – № 12. – С. 37-43. Galstyan G.M., Kesel`man S.A., Gorodetskiy V.M. Aleksanyan M. Zh., Kulikov S.M., Gemdzhyan E.G., Parovichnikova E.N., Savchenko V.G., Vorobyov A. I. Sochetannoe provedenie khimioterapii gemoblastozov i terapii ostroy dykhatel`noy nedostatochnosti v reanimatsionnykh usloviyakh [Combined chemotherapy Leukemia and treatment of acute respiratory failure in intensive care conditions]. Terapevticheskiy arkhiv – Therapeutic archive, 2009, no. 12, pp. 37-43.
4. Ковалева Л.Г. Острые лейкозы. – М.: Медицина, 1990. – 212 с. Kovaleva L.G. Ostrye leykozy [Acute leukemias]. Moscow, Medicine, 1990. 212 p.
5. Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови биолюминесцентным методом // Лабораторное дело. – 1989. – № 11. – С. 23-25. Savchenko A.A., Suntsova L.N. Vysokochuvstvitel`noe opredelenie aktivnosti degidrogenaz v limfotsitakh perifericheskoy krovi biolyuminestsentnym metodom [Highly sensitive determination of dehydrogenase activity in peripheral blood lymphocytes bioluminescent method]. Laboratornoe delo – Laboratory Work, 1989, no. 11, pp. 23-25.
6. Смирнова О.В. Хронический миелолейкоз – клинические и иммунологические особенности у взрослых больных // Бюллетень Восточно-сибирского научного центра Сибирского отделения Российской академии медицинских наук. – 2012. – № 3 (85) часть 2. – С. 185-189. Smirnova O.V. Hronicheskiy mieloleykoz - klinicheskie i immunologicheskie osobennosti u vzroslykh bol`nykh [Chronic myelogenous leukemia - clinical and immunological features of adult patients]. Byulleten` Vostochno-sibirskogo nauchnogo tsentra Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk – Bulletin of the East-Siberian Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, 2012, no. 3 (85) part 2, pp. 185-189.
7. Смирнова О.В., Манчук В.Т. Особенности прогнозирования возникновения инфекционных осложнений после проведения химиотерапии у больных острыми лейкозами // Медицинская иммунология. – 2012. – Т. 14, № 4-5. – С. 403-408. Smirnova O.V., Manchuk V.T. Osobennosti prognozirovaniya vozniknoveniya infektsionnykh oslozhneniy posle provedeniya khimioterapii u bol`nykh ostrymi leykozami [Features predicting the occurrence of infectious complications after chemotherapy in patients with acute leukemia]. Meditsinskaya immunologiya – Medical Immunology, 2012, vol. 14, no. 4-5, pp. 403-408.
Review
For citations:
Smirnova O.V., Manchuk V.T. FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA. Medical Immunology (Russia). 2013;15(6):577-584. (In Russ.) https://doi.org/10.15789/1563-0625-2013-6-577-584